Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD
0.0760
+0.0005 (0.66%)
Mar 11, 2026, 2:44 PM AEST
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
Pharmaceutical Development | 3.44M | 1.95M | 1.45M | 295.81K | 996.26K | | | | | |
Pharmaceutical Development Growth | 76.22% | 34.20% | 391.76% | -70.31% | - | | | | | |
| 3.44M | 1.95M | 1.45M | 295.81K | 996.26K | | | | | |
| 76.22% | 34.20% | 391.76% | -70.31% | - | | | | | |
Source: S&P Global Market Intelligence.
